Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency VAN Library Missing | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency CN Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.2 BC Cancer Agency VAN Library | Available | ||
c.3 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
Table of contents:; History of Cancer Immunotherapy -- Section I: Basic Principles of Tumor Immunology -- Section II: Cancer Immunotherapy Targets and Classes -- Section III: Immune Function in Cancer Patients -- Section IV: Disease-Specific Treatments and Outcomes -- Section V: Regulatory Aspects …
Contents:; The cancer problem in children -- Leukemias in children -- Supratentorial brain tumors -- Tumors of the posterior fossa and the spinal canal -- Retinoblastoma -- Neuroblastoma -- Hodgkin lymphoma -- Non-Hodgkin lymphoma -- Ewing sarcoma -- Osteosarcoma, chordoma, and chondrosarcoma -- Rh…
c.1 BC Cancer Agency VAN Library REF | Available |
c.1 BC Cancer Agency VIC Library | On Loan, due Wednesday, June 5, 2024 | ||
c.4 BC Cancer Agency VAN Library | On Loan, due Tuesday, June 11, 2024 | ||
c.2 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.3 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.2 BC Cancer Agency ARHCC Library | Available | ||
c.2 BC Cancer Agency CN Library Missing | Available | ||
c.1 BC Cancer Agency KEL Library Missing | Available | ||
c.2 BC Cancer Agency KEL Library | Available | ||
c.7 BC Cancer Agency VAN Library | Available | ||
c.2 BC Cancer Agency SUR Library Missing | Available | ||
c.2 BC Cancer Agency VAN Library | Available | ||
c.5 BC Cancer Agency VAN Library | Available | ||
c.3 BC Cancer Agency VIC Library | Available | ||
c.3 BC Cancer Agency ARHCC Library | Available | ||
c.6 BC Cancer Agency VAN Library | Available | ||
c.3 BC Cancer Agency KEL Library | Available | ||
c.3 BC Cancer Agency CN Library | Available | ||
c.1 BC Cancer Agency CN Library | Available | ||
c.4 BC Cancer Agency SUR Library Missing | Available |
Table of Contents:; 1. Executive Summary -- 1.1 Background -- 1.2 Scope -- 1.3 Conclusions and Recommendations -- 1.3.1 General -- 1.3.2 Operational Health Physics -- 1.3.3 Internal Dosimetry -- 1.3.4 Summary -- 2. Introduction -- 2.1 Background -- 2.2 Purpose -- 3. Types and Sources of Nanomateria…